PUTRAJAYA: The Health Ministry has revoked the notification of cosmetic products Beaute Treatment Cream and Beaute Nite Cream, which can no longer be sold in Malaysia as they have been found to contain scheduled poisons.
Health director-general said Beaute Treatment Cream was detected to contain hydroquinone, tretinoin and betamethasone 17-valerate, while Beaute Nite Cream had mercury and betamethasone 17-valerate.
He said products that contain hydroquinone, tretinoin and betamethasone 17-valerate need to be registered with the Drug Control Authority and could only be used with the advice of health professionals.
“The use of products containing the substances without the supervision of health professionals could lead to unwanted side effects,” he said in a statement on Friday (Sept 15).
He said mercury could be absorbed into the body and cause damage to the kidneys and nervous system, as well as disrupt the brain development of young or unborn children, besides causing rashes, irritation and other changes to the skin.
“Hydroquinone can cause skin redness, discomfort, skin discolouration and hypersensitivity.
“It can also inhibit the pigmentation process (depigmentation), which reduces the skin’s protection from harmful ultraviolet rays, thus increasing the risk of skin cancer,” he said.
The use of tretinoin could cause redness of the skin, discomfort, stinging, peeling and sensitivity to sunlight, while betamethasone 17-valerate can cause thinning of the facial skin, irritation, acne, changes in skin pigmentation and increase the risk of being absorbed into the blood circulation system, which can have harmful effects.
Dr Muhammad Radzi said the sale and distribution of these products should stop immediately as it violates the Control of Drugs and Cosmetics Regulations 1984.
Those in breach of the regulations can be fined up to RM25,000 or jailed up to three years, or both, if convicted.
For subsequent offences, they would be liable to a fine of up to RM50,000 or jailed up to five years, or both, upon conviction.
Companies could be fined up to RM50,000 for the first offence and RM100,000 for subsequent offences.
“Consumers are advised to stop using the products immediately and seek the advice of healthcare professionals if they experience any discomfort or adverse effects,” he said.
